Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein

Neuroscience Letters

Volumn 229, Issue 2, 1997, Pages 85-88

  Lindh, Maria ^a   Blomberg, Mari ^b   Jensen, Malene ^a   Basun, Hans ^b   Lannfelt, Lars ^a   Engvall, Benita ^a   Scharnagel, Hubert ^c   März, Winfried ^c   Wahlund, Lars Olof ^b   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cerebrospinal fluid; Diagnostic marker; Tau protein

Indexed keywords

APOLIPOPROTEIN E; BIOCHEMICAL MARKER; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 0030801045     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00429-1     Document Type: Article

References (15)

1. Blennow, K., Hesse, C. and Fredman, P., Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease, NeuroReport, 5 (1994) 2534-2536.
2. Blomberg, M., Jensen, M., Basun, H., Lannfelt, L. and Wahlund, L.-O., Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ∈4 during 14 months follow up, Neurosci. Lett., 214 (1996) 163-166.
3. Carlsson, J., Armstrong, V.W., Reiber, H., Felgenhauer, K. and Seidel, D., Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid, Clin. Chim. Acta, 196 (1991) 167-176.
4. Hahne, S., Nordstedt, C., Åhlin, A. and Nybäck, H., Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy control, Neurosci. Lett., 224 (1997) 99-102.
5. Ignatius, M.J., Gebicke-Härter, P.J., Skene, J.H.P., Schilling, J.W., Weisgraber, K.H., Mahley, R.W. and Shooter, E.M., Expression of apolipoprotein E during nerve degeneration and regeneration, Proc. Natl. Acad. Sci. USA, 83 (1986) 1125-1129.
6. Jensen, M., Basun, H. and Lannfelt, L., Increased cerebrospinal fluid tau in patients with Alzheimer's disease, Neurosci. Lett., 186 (1995) 189-191.
7. Landén, M., Hesse, C., Fredman, P., Regland, B., Wallin, A. and Blennow, K., Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced without any correlation to the apoE4 isoform, Dementia, 7 (1996) 273-278.
8. Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H. and Delacourte, A., Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease, Neurosci. Lett., 212 (1996) 91-94.
9. Lovestone, S., Anderton, B.H., Hartley, C., Jensen, T.G. and Jörgensen, A.L., The intracellular fate of apolipoprotein E is tau dependent and apoE allele-specific, NeuroReport, 7 (1996) 1005-1008.
10. Merched, A., Blain, H., Visvikis, S., Herbeth, B., Jeandel, C. and Siest, G., Cerebrospinal fluid apolipoprotein E level is increased in late onset Alzheimer's disease, J. Neurol. Sci., 145 (1997) 33-39.
11. Nathan, B.P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R.W. and Pitas, R.E., The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization, J. Biol. Chem., 270 (1995) 19791-19799.
12. Roses, A.D., On the metabolism of apolipoprotein E and the Alzheimer diseases, Exp. Neurol., 132 (1995) 149-156.
13. Rosler, N., Wichart, I. and Jellinger, K.A., Intra vitam lumbar cerebrospinal fluid and serum and ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 60 (1996) 452-454.
14. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D., Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 11183-11186.
15. Strittmatter, W.J., Weisgraber, K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.H., Hulette, C., Einstein, G., Schmechel, D., Pericak-Vance, M.A. and Roses, A.D., Hypothesis: microtubule instability and paired helical filaments formation in the Alzheimer's disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125 (1994) 163-171.